Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Docetaxel + Capecitabine + Oxaliplatin vs Capecitabine + Oxaliplatin as Adjuvant Chemotherapy in Stage IIIB/IV (M0) Gastric Cancer After Radical Resection
KCT0004525Phase 3Recruiting
- Sponsor
- Asan Medical Center
- Start
- Oct 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, capecitabine, oxaliplatin in gastric cancer (GC), sponsored by Asan Medical Center. Started Oct 2013; status: recruiting.
02
Drugs
docetaxelcapecitabineoxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0004525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004525.